Browse Arkansas Code titles and sections
42 U.S.C. § 285k — National Institute of General Medical Sciences
Federal law — U.S. Code and appendices · legal_authorities
**(a) General purpose** The general purpose of the National Institute of General Medical Sciences is the conduct and support of research, training, and, as appropriate, health information dissemination, and other programs with respect to general or basic medical sciences and related natural or behavioral sciences which have significance for two or more other national research institutes or are outside the general area of responsibility of any other national research institute.
**(b) Institutional development award program**
(1)
(A) In the case of entities described in subparagraph (B), the Director of NIH, acting through the Director of the National Institute of General Medical Sciences, shall establish a program to enhance the competitiveness of such entities in obtaining funds from the national research institutes for conducting biomedical and behavioral research.
(B) The entities referred to in subparagraph (A) are entities that conduct biomedical and behavioral research and are located in a State in which the aggregate success rate for applications to the national research institutes for assistance for such research by the entities in the State has historically constituted a low success rate of obtaining such funds, relative to such aggregate rate for such entities in other States.
(C) With respect to enhancing competitiveness for purposes of subparagraph (A), the Director of NIH, in carrying out the program established under such subparagraph, may—
(i) provide technical assistance to the entities involved, including technical assistance in the preparation of applications for obtaining funds from the national research institutes;
(ii) assist the entities in developing a plan for biomedical or behavioral research proposals; and
(iii) assist
Source: Supplied U.S. Code snapshot — release unconfirmed · 42 U.S.C. § 285k
Stored review status: release_metadata_unconfirmed. A text match is a research starting point; applicability is not established.
Original supplied file — preserved unchanged
Download original Markdown file
File SHA-256: acdff9016ab865c253574c107d224cc58df7d9bc3f6c7259bb1da385de2a8e2d. The original may include catalog metadata, neighboring provisions, or embedded records outside this collection's scope. Search shows only the selected federal record. Historical editions and unverified snapshots are not a statement of current law.
Authority boundary: historical or unconfirmed source not current law verified.
Open the recorded source website ↗
Record provenance
Stable record: federal_law:legal_authorities:record_usc_4ec3eebf3dd5b61158767250
Source file: Laws/federal/codes/united-states-code/title-42/section-285k-national-institute-of-general-medical-sciences--e2b6142caa.md
Pages: Not recorded – Not recorded
Passage SHA-256: 2b53b5c541abb94a21511515fa1d6b8ffdd8ad86af83cdf017e0eac029c4bac6
Source location: Title 42, Chapter 6A, § 285k; chapter-6a-public-health-service.md
Stored source content
**(a) General purpose** The general purpose of the National Institute of General Medical Sciences is the conduct and support of research, training, and, as appropriate, health information dissemination, and other programs with respect to general or basic medical sciences and related natural or behavioral sciences which have significance for two or more other national research institutes or are outside the general area of responsibility of any other national research institute.
**(b) Institutional development award program**
(1)
(A) In the case of entities described in subparagraph (B), the Director of NIH, acting through the Director of the National Institute of General Medical Sciences, shall establish a program to enhance the competitiveness of such entities in obtaining funds from the national research institutes for conducting biomedical and behavioral research.
(B) The entities referred to in subparagraph (A) are entities that conduct biomedical and behavioral research and are located in a State in which the aggregate success rate for applications to the national research institutes for assistance for such research by the entities in the State has historically constituted a low success rate of obtaining such funds, relative to such aggregate rate for such entities in other States.
(C) With respect to enhancing competitiveness for purposes of subparagraph (A), the Director of NIH, in carrying out the program established under such subparagraph, may—
(i) provide technical assistance to the entities involved, including technical assistance in the preparation of applications for obtaining funds from the national research institutes;
(ii) assist the entities in developing a plan for biomedical or behavioral research proposals; and
(iii) assist the entities in implementing such plan.
(2) The Director of NIH shall establish a program of supporting projects of biomedical or behavioral research whose principal researchers are individuals who have not previously served as the principal researchers of such projects supported by the Director.
Cross-references
Connections may be documented source relationships, shared citations or nearby passages. Each explains its basis; a connection alone does not establish applicability to your situation.
Federal law — U.S. Code and appendices · legal_authorities
**(a) Appointment** The National Institutes of Health shall be headed by the Director of NIH who shall be appointed by the President by and with the advice and consent of the Senate. The Director of NIH shall perform functions as provided under subsection (b) and as the Secretary may otherwise prescribe.
**(b) Duties and authority** In carrying out the purposes of [section 241 of this title](https://uscode.house.gov/view.xhtml?req=granuleid:USC-prelim-title42-section241&num=0&edition=prelim), the Secretary, acting through the Director of NIH—
(1) shall carry out this subchapter, including being responsible for the overall direction of the National Institutes of Health and for the establishment and implementation of general policies respecting the management and operation of programs and activities within the National Institutes of Health;
(2) shall coordinate and oversee the operation of the national research institutes, national centers, and administrative entities within the National Institutes of Health;
(3) shall, in consultation with the heads of the national research institutes and national centers, be responsible for program coordination across the national research institutes and national centers, including conducting priority-setting reviews, to ensure that the research portfolio of the National Institutes of Health is balanced and free of unnecessary duplication, and takes advantage of collaborative, cross-cutting research;
(4) shall assemble accurate data to be used to assess research priorities, including—
(A) information to better evaluate scientific opportunity, public health burdens, and progress in reducing health disparities; and
(B) data on study populations of clinical research, funded by or conducted at each national research institute and
Source: Supplied U.S. Code snapshot — release unconfirmed · 42 U.S.C. § 282
Stored review status: release_metadata_unconfirmed. Explicit cross-reference supplied in source Markdown; currentness and applicability require review.
Federal law — U.S. Code and appendices · legal_authorities
Page 744
TITLE 42—THE PUBLIC HEALTH AND WELFARE
§ 285j–1
Editorial Notes
AMENDMENTS
1989—Pub. L. 101–93 substituted ‘‘disease and’’ for
‘‘disease and and’’.
1988—Pub. L. 100–553 and Pub. L. 100–607 made iden-
tical amendments, substituting ‘‘Neurological Dis-
orders’’ for ‘‘Neurological and Communicative Dis-
orders’’ and ‘‘and disorder and stroke’’ for ‘‘disorder,
stroke, and disorders of human communication’’. Pub.
L. 100–690 amended this section to read as if the amend-
ments by Pub. L. 100–607 had not been enacted.
Statutory Notes and Related Subsidiaries
EFFECTIVE DATE OF 1988 AMENDMENT
For effective date of amendment by Pub. L. 100–690,
see section 2613(b)(1) of Pub. L. 100–690, set out as an Ef-
fect of Enactment of Similar Provisions note under sec-
tion 285m of this title.
§ 285j–1. Spinal cord regeneration research
The Director of the Institute shall conduct
and support research into spinal cord regenera-
tion.
(July 1, 1944, ch. 373, title IV, § 458, as added Pub.
L. 99–158, § 2, Nov. 20, 1985, 99 Stat. 857.)
Statutory Notes and Related Subsidiaries
INTERAGENCY COMMITTEE ON SPINAL CORD INJURY
Pub. L. 99–158, § 7, Nov. 20, 1985, 99 Stat. 881, provided
that:
‘‘(a) ESTABLISHMENT.—Within 90 days after the date of
enactment of this Act [Nov. 20, 1985], the Secretary of
Health and Human Services shall establish in the Na-
tional Institute of Neurological and Communicative
Diseases and Stroke an Interagency Committee on Spi-
nal Cord Injury (hereafter in this section referred to as
the ‘Interagency Committee’). The Interagency Com-
mittee shall plan, develop, coordinate, and implement
comprehensive Federal initiatives in research on spinal
cord injury and regeneration.
‘‘(b) COMMITTEE COMPOSITION AND MEETINGS.—(1) The
Interagency Committee
Source: Supplied 2024 U.S. Code historical extraction · 42 U.S.C. § 285k
Stored review status: historical_2024_not_currentness_verified. Same stored citation; legal effect and authority still require review.